The Washington Post examines H1N1 vaccine supplies across the U.S.: “With only a fraction of the tens of millions of doses of vaccine that authorities predicted would be available arriving in states, cities and towns, public health officials who spent months planning for a massive immunization program are instead scrambling to parcel out their limited supply of nasal sprays and shots,” the newspaper writes.
Agence France-Presse examines how two recent studies have “boosted morale” among HIV vaccine researchers who have struggled for decades to develop a viable vaccine to protect people from the virus.
Wednesday’s release of the WHO, UNICEF and the World Bank joint report on childhood vaccines highlighted gains in recent global vaccination campaigns and also found that nearly 24 million infants worldwide don’t get the recommended first-year vaccination. The following news outlets examined the challenges associated with the expansion of global immunization campaigns to reach this population:
Nigeria Gets $669M Global Fund Grant For Health System Strengthening The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. “During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and…
A joint report by the WHO, UNICEF and the World Bank on worldwide vaccination efforts released Wednesday found “a record 106 million infants were vaccinated last year against life-threatening diseases, but nearly a fifth of the world’s babies still are not protected fully,” the Associated Press reports.
As the AIDS vaccine conference continues in Paris this week, Reuters examines how recent trials are helping researchers better understand ways to develop a vaccine that offers people protection from HIV. Researchers involved in Merck’s AIDS vaccine trial, which was halted in 2007 after it was feared the vaccine raised study participants’ risk of infection, presented follow-up data from the trial during the conference on Tuesday.
As HIV Vaccine Conference Opens, Experts Appeal For Sustained Commitment To Global Fight Against Disease
Experts gathered for the start of a four-day conference on HIV vaccines in Paris called upon donors to maintain their funding support for the fight against HIV/AIDS despite the global economy, Agence France-Presse reports.
Opinions: HIV Vaccine; HIV Resources Help Promote Global Disease Control; U.S. Fight Against World Hunger
New York Times Opinion ExaminesÂ HIV Vaccine Research Seth Berkley, president and chief executive of the International AIDS Vaccine Initiative, in a New York Times opinion pieceÂ examines how the “pessimism” over the recent controversy surrounding the results of an experimental HIV vaccine tested in Thailand “may ultimately thwart other efforts to…
As countries around the world roll out H1N1 (swine flu) virus vaccine campaigns, the Atlantic examines, “[W]hat if everything we think we know about fighting influenza is wrong?”
New studies suggest that “[d]eveloping countries with limited access to advanced health-care facilities may be in for a rough ride with swine [H1N1] flu and even countries with high-tech ICUs may find themselves pushed to the limit as their hospitals struggle to save gravely ill H1N1 patients,” the Canadian Press reports. The studies, which compare outcomes among H1N1 patients admitted to intensive care units in Canada and Mexico,” show “the death rate in the latter was more than double that seen among Canadian patients. Just over 40 percent of critically ill Mexican patients succumbed to their illness by day 60, compared to 17.3 percent of Canadian patients by day 90.” The findings were reported online in the Journal of the American Medical Association (JAMA) on Monday.